BreakThrough Digest offers current medical news and health articles on medical breakthroughs, medical research and health information on clinical trials,
cancer, Alzheimer's, stem-cell research, heart disease, diabetes and more.
Neprinol - exclusive distributors of pharmaceutical-grade products including neprinol, syntol, and devacor
Chelation - cardio renew is 100% pure edta providing cardiovascular cleansing by oral chelation.
Bladder Cancer & Research in the News
Disease affects men 3 times more than women - Today's THV Bladder cancer is the result of cell changes in the inside wall of the bladder and is caused by changes in the cells' chromosomes or DNA. Bladder cancer develops in most people between the ages of 60 and 79. In most cases, it's caused by external ...
OncoMethylome Sciences (BE) - OncoMethylome Sciences ... - Phramalive.com ... the period ended December 31, 2009. 2009 operational highlights: Starting at the end of 2009, OncoMethylome focused its R&D efforts on four core areas: colorectal cancer screening, bladder cancer detection, prostate cancer detection, and ...
Bladder Cancer Therapeutics - A Global Strategic ... - PR Inside www.companiesandmarkets.com/Summary-Market-Report/bladder-cancer .. This 557 page report analyzes the worldwide markets for Bladder Cancer Therapeutics in US$ Million. The report provides separate comprehensive analytics for US, Japan, Europe, and ...
New drugs, approaches offer hope against prostate ... - WALB 10 ... stubborn forms of prostate cancer. The new hope comes from three studies being presented this week at the annual Genitourinary Cancers Symposium in San Francisco. "Genitourinary cancers include cancers of the prostate, kidney, bladder and ...
Peer-reviewed Research Elucidates Function of Hsp27 ... - Earthtimes ... announced the first patient dosed in an open label, dose-escalation, Phase 1 clinical trial evaluating OGX-427 when administered directly into the bladder in patients with bladder cancer. The study, which will enroll up to 36 patients with ...
OncoMethylome Sciences Announces 2009 Financial Results - Investors Business Daily ... the period ended December 31, 2009. 2009 operational highlights: Starting at the end of 2009, OncoMethylome focused its R&D efforts on four core areas: colorectal cancer screening, bladder cancer detection, prostate cancer detection, and ...
Cancer treatment for men: Possible sexual side effects - MayoClinic.com ... with cancer in their pelvic area are more likely than are men with other cancers to report difficulty resuming sex after cancer treatment. Sexual side effects are most common after treatment for: Bladder cancer Colon cancer Prostate cancer ...
Research and Markets: Bladder Cancer Therapeutics ... - Forbes BusinessWire - Research and Markets (http://www.researchandmarkets.com/research/2aca55/bladder_cancer_the) has announced the addition of the "Bladder Cancer Therapeutics - Global Strategic Business Report" report to their offering. This report ...
Cancer survivor helps plan Relay - Carthage Press Don has been a supporter of the Relay long before he himself was stricken with bladder cancer in August of 2006. He and Kathy have even travelled to and attend a Relay For Life Event in Georgia! Don is diabetic so when he started to see blood in ...
BreakThrough Digest Copyright 2007 BreakThrough Digest BreakThrough Digest subscribes to the eHealth Code of Ethics
medical new and medical breakthroughs health information and health articles about medicine on cancer, heart disease, diabetes and stem cell research
